Revenue Recognition Principles Negatively Impact The Biotechnology Industry, New Study Confirms Current revenue recognition accounting principles continue to place unnecessary challenges on small and medium-sized biotechnology companies who enter into collaborative arrangements, according to an independent study released today by the Biotechnology Industry Organization (BIO). The study, entitled "Revenue Recognition for Collaborative Arrangements in the Biotechnology Industry, was conducted by Glass, Lewis, & Co., LLC, a leading research and professional services firm.
Source: www.medicalnewstoday.comLifestyle And Testicular Dysfunction: A Brief Update UroToday.com - A variety of testicular pathologies to include testicular cancer, cryptorchidism and defective spermatogenesis have been increasing. While genetic factors play a role, growing evidence suggests that the testicle is damaged by environment and lifestyle-related factors either prenatally or at puberty.
Source: www.medicalnewstoday.comSexually Transmissible Infections And Prostate Cancer Risk UroToday.com - Circulating antibodies against infectious agents and self-reported history of syphilis and gonorrhea represent an individual's cumulative lifetime exposure or past infections, and thus are particularly suited for risk evaluation of cancer with a long latent disease process.
Source: www.medicalnewstoday.comTennessean Editorials, Opinions Discuss FDA Investigation Drug List The Tennessean on Thursday published an editorial and two opinion pieces about an FDA decision to publish online a quarterly list of
drugs being investigated for potential safety risks. Summaries appear below.
Source: www.medicalnewstoday.comBBC Headroom Is Cracking Up For World Mental Health Day This week, as the world's attention turns to issues of good mental
health for Friday's World Mental
Health Day, BBC Learning's own mental
health and wellbeing campaign - BBC Headroom - celebrates with the transmission of Alastair Campbell's moving film, Cracking Up, some new faces at bbc.co.uk/headroom and a dedicated action line: 08000 933 193[i].
Source: www.medicalnewstoday.comThe Case For Prostate-Specific Antigen Screening Starting At Age 40 UroToday.com - Dr. Robert Nadler, of Northwestern University, wrote an excellent editorial in a recent issue of Cancer regarding the commencement of prostate cancer (CaP) screening at age 40. The National Comprehensive Cancer Care Network (NCCN) recommends an initial PSA at age 40 for men of all races. The frequency of subsequent PSA tests would depend on the initial level.
Source: www.medicalnewstoday.comDrug Companies Plan To Invest In HIV/AIDS Drug Development, Improve Access, U.N. Secretary-General Says United Nations Secretary-General Ban Ki-moon on Thursday said that many large pharmaceutical companies -- including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer -- plan to increase their efforts to develop HIV/AIDS
drugs and diagnostics for impoverished regions, Reuters reports.
Source: www.medicalnewstoday.comWisconsin's Biotechnology & Medical Device Association Applauds Historic Genomic Research Initiative The following is a statement by Jim Leonhart, executive director of the Wisconsin Biotechnology & Medical Device Association, regarding this morning's announcement by Gov. Jim Doyle of the Wisconsin Genomics Initiative. The initiative is a public-private partnership that includes Marshfield Clinic, the Medical College of Wisconsin, the University of Wisconsin School of
Medicine and Public
Health, and UW-Milwaukee. "Today's historic announcement by Gov.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 PM
